Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/981419226
总结
Allele G is associated with increased progression-free survival (PFS) time when treated with erlotinib or gefitinib in EGFR mutation positive non-small-cell lung cancer patients as compared to allele T.